NOVEMBER , 2023 | THE HEALTH

THIS YEAR , Stanford University ranked 14 researchers from Universiti Tunku Abdul Rahman ( UTAR ) in the top two per cent of scientists worldwide .

Stanford University listed the top two per cent of scientists in various scientific fields using Scopus author profiles as of Oct 1 , 2023 .

In a statement , UTAR commended all individuals in the top two percentile of global scientists .

The following people are included on the list :

• Emeritus Professor Dr Boo Nem Yun @

Mooi Nam Ying for General and Internal Medicine

• Ir Prof Dr Chung Boon Kuan for Information and Communication

• Ir Prof Dr Ong Kok Seng for Energy

• Prof Dr Mohammed J . K . Bashir for Environmental Sciences

• Prof Ts Dr Yau Kok Lim for Networking & Telecommunications

• Prof Dr Sumathi Sethupathi for the Chemical Engineering field The Stanford University team , led by Professor John Loannidis prepared the list .

A statement was released stating that the updated database ( version 6 ) offers “ standardised information on citations , h-index , co-authorship-adjusted hm-index , citations to papers in different authorship positions , and a composite indicator .”

The clinical trial ’ s results were delivered as a late-breaking oral presentation at the AACR-NCI- EORTC International Conference 2023 in Boston , US . Dr Voon was listed as a co-author in this prestigious platform due to his noteworthy contribution to the First-in-Human trial .

The said trial , which was started at SGH in June of this year , places SGH and Dr Voon in the company of internationally renowned cancer institutes , such as the Memorial Sloan Kettering Cancer Centre ( 2nd in the world ) and the Dana- Faber Cancer Institute ( 8th in the world ), both of which are situated in the US .

Additionally , Dr Voon was recognised as the First Recruiter for the Region for this First-in- Human clinical trial , which aims to evaluate the safety and potential anti-tumor effects of an investigational product ; a first-in-class KRASG12C inhibitor in patients with advanced solid tumours with KRASG12C mutations .

He credited the hard work of his Study Coordinators , Erfan and Li Fang , as well as the staff of the SGH Clinical Research Centre ( CRC ) team , who were instrumental to the clinical

SINGAPORE-BASED healthcare group Thomson Medical Group Limited has appointed Lee Suen Ming as its new CEO .

Prior to most recently serving as CEO of the Dr Soliman Fakeeh Hospital in Saudi Arabia , Lee served as CEO of the Mount Alvernia Hospital , Gleneagles Hospital , Parkway East Hospital , and Mount Alvernia Hospital . He will succeed Dr Daniel Lee , effective Nov 1 .

According to Dr Melvin Heng , the Group CEO of the SGX-listed Thomson Medical Group , Lee ’ s appointment comes at a “ pivotal point in a growth story that we kicked-started a year ago .”

The organisation intends to expand regionally . In July , it acquired FV Hospital , a multi-speciality healthcare facility in Vietnam , for US $ 381.4 million . This healthcare agreement has represented the biggest in Southeast Asia

trial ’ s execution , for his success .

The success of Clinical Research Malaysia ’ s Phase 1 Realisation Project ( P1RP ), which was launched in 2016 as a five-year plan to make sure the nation was prepared for the safe and effective conduct of early phase research , is attested to by the advancements Malaysia has made in the field of early phase clinical research .

CRM , a corporatised site management organisation wholly owned by the Ministry of Health , provided all funding and carried out the P1RP project .

Many of the nation ’ s firsts were accomplished from this project , including developing the Malaysia Phase 1 Clinical Trial Guidelines , establishing a Phase 1 accredited facility in SGH and establishing a Scientific Review Panel .

CRM also sponsored the training and development of three National Pharmaceutical Regulatory Agency officers in 2017 and 2018 and Dr Voon in 2020 .

While the P1RP concluded in 2021 with the return of Dr Voon from his fellowship training at the Princess Margaret Cancer Center in Toronto , CRM embarked on P1RP 2.0 to further expand its investment in human capital development , particularly in training and attachment of clinical research study coordinators and clinicians in early phase centres , and attracting more early phase trials into Malaysia .

since 2020 and the largest in Vietnam .

Beyond Vietnam , Thomson Medical Group is also actively seeking investment opportunities in Indonesia . The Group ’ s operations in Malaysia are under TMC Life Sciences Berhad , a multidisciplinary healthcare company listed on Bursa Malaysia .

To ensure a smooth transition , it was announced that Dr Daniel Lee would stay with the group and work alongside Lee through the end of November .

Lee will be in charge of the 187-bed Thomson Medical Centre , a network of over 30 specialised medical facilities , and service offerings in medical aesthetics , traditional Chinese medicine , and diagnostic imaging .

SUNWAY GROUP Founder and Chairman Tan Sri Jeffrey Cheah has been named an honorary Knight Commander of the Most Excellent Order of the British Empire ( KBE ) by His Majesty King Charles III of the UK .

Sunway Group is one of Southeast Asia ’ s leading conglomerates with core interests in healthcare , real estate , property , construction , education and hospitality .

Furthermore , he plays a pivotal role as the founder and trustee of the Jeffrey Cheah Foundation , which oversees all entities within Sunway Education Group , emphasising his significant dedication to advancing healthcare and education initiatives .

According to a statement issued by the British High Commission , Cheah was honoured for his services to higher education , health and philanthropy .

The honorary knighthood , denoted by the post-nominal letters KBE , is a highly prestigious and rare distinction for citizens of a non- Commonwealth Realm nation .

“ This honour bestowed on Cheah is only the second in Malaysia in recent times and the first conferred by His Majesty King Charles III on a citizen of Malaysia .

In healthcare , the statement said the partnership with the University of Cambridge saw the Group ’ s flagship Sunway Medical Centre at Sunway City Kuala Lumpur appointed as a Regional Site Partner of Cambridge University Clinical Research Centre , as well as the naming of the Jeffrey Cheah Biomedical Centre at the Cambridge University Biomedical Campus , the largest biotech cluster outside the United States .

“ In addition to playing a pivotal role in the UK ’ s response towards Covid-19 , the Jeffrey Cheah Biomedical Centre houses more than 300 scientists conducting cutting-edge research to address the latest and emerging public health challenges ,” it said .

Through the realms of business and philanthropy , the British High Commission said Cheah ’ s relentless drive to learn from the best and work with the best led to high-level partnerships between Sunway , the Jeffrey Cheah Foundation and renowned institutions in the UK such as the University of Cambridge , the University of Oxford , Lancaster University and the Royal College of Physicians .

British High Commissioner to Malaysia Ailsa Terry congratulated Cheah and described him as a remarkable businessman who developed and guided the Sunway Group into a prosperous conglomerate with investments in the UK . – The Health